The Food and Drug Administration has approved a device that uses electrical stimulation to reduce inflammation from ...

Rheumatoid arthritis (RA) impacts thousands of Australians each year, causing pain, stiffness, and a steady decline in strength. As many as 2% of adults face the daily challenges of this condition, ...

Any joint can become arthritic, but the most commonly affected areas of the body are the knees, hands, hips, feet and lower back - getty For many of us, aches and pains, sore joints and stiffness are ...

Dana Orange’s research may help predict flares, provide precise drug targets, and enable interventions that block symptoms ...

And find out whether glucosamine supplements, joint braces and cushioned running shoes are worth splurging on to protect your ...

Results show that GLP-1s may address rheumatoid arthritis (RA) symptoms, independent of established weight loss and cardiac benefits, by reducing the systemic, chronic inflammation associated with RA.

Non-steroidal anti-inflammatory drugs (NSAIDs) and steroids (see Corticosteroid Therapy) can be useful for acute pain relief in patients with rheumatoid arthritis (RA). In osteoarthritis, studies have ...

Everyday movements, like climbing stairs or squatting, are often accompanied by a nagging stiffness that many brushes off as ...

GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the medication — and that's been life-changing for Cassandra Smith.

Signs of immune system aging appear years before rheumatoid arthritis takes hold, offering new hope for early diagnosis and ...

Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognised useful secondary effect to lower ...